Tag Archives: Novartis

TB advocates call on organizations, leaders to work together, speed access to existing treatments for drug resistant tuberculosis

By on .

They would like an answer on March 24 When World TB Day next Tuesday commemorates the discovery in 1882 of the bacteria that causes the disease, announcements and op-ed pieces will note the progress that has been made since, and will certainly call for more. A group of 89 organizations that last week sent a […]

India’s patent laws, public health response without public healthcare and bridging the Global Fund gap . . .

By on .

India’s patent laws: This Lancet special report on legal challenges by Bayer and Novartis to applications of India’s Patents Act provides a link to the 2010 United Nations Development Program’s report on the nation’s efforts to supply affordable HIV treatment in the context of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). It […]